{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T10:48:15Z","timestamp":1774003695340,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T00:00:00Z","timestamp":1488758400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1208\/s12248-017-0055-y","type":"journal-article","created":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T11:35:18Z","timestamp":1488800118000},"page":"712-726","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Exploring Canine-Human Differences in Product Performance. Part II: Use of Modeling and Simulation to Explore the Impact of Formulation on Ciprofloxacin In Vivo Absorption and Dissolution in Dogs"],"prefix":"10.1208","volume":"19","author":[{"given":"M. N.","family":"Martinez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Mistry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Lukacova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. A.","family":"Lentz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. E.","family":"Polli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. W.","family":"Hoag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Dowling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Kona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. M.","family":"Fahmy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,3,6]]},"reference":[{"key":"55_CR1","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0939-6411(99)00070-3","volume":"49","author":"M Akimoto","year":"2000","unstructured":"Akimoto M, Nagahata N, Furuya A, Fukushima K, Higuchi S, Suwa T. Gastric pH profiles of beagle dogs and their use as an alternative to human testing. Eur J Pharm Biopharm. 2000;49:99\u2013102.","journal-title":"Eur J Pharm Biopharm"},{"key":"55_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/jps.2600750313","volume":"75","author":"CY Lui","year":"1986","unstructured":"Lui CY, Amidon GL, Berardi RR, Fleisher D, Youngberg C, Dressman JB. Comparison of gastrointestinal pH in dogs and humans: implications on the use of the beagle dog as a model for oral absorption in humans. J Pharm Sci. 1986;75:271\u20134.","journal-title":"J Pharm Sci"},{"key":"55_CR3","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1002\/jps.21499","volume":"98","author":"MN Martinez","year":"2009","unstructured":"Martinez MN, Papich MG. Factors influencing the gastric residence of dosage forms in dogs. J Pharm Sci. 2009;98:844\u201360.","journal-title":"J Pharm Sci"},{"key":"55_CR4","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1208\/s12248-015-9743-7","volume":"17","author":"MG Papich","year":"2015","unstructured":"Papich MG, Martinez MN. Applying Biopharmaceutical Classification System (BCS) criteria to predict oral absorption of drugs in dogs: challenges and pitfalls. AAPS J. 2015;17:948\u201364.","journal-title":"AAPS J"},{"key":"55_CR5","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/S0169-409X(02)00071-6","volume":"54","author":"M Martinez","year":"2002","unstructured":"Martinez M, Amidon G, Clarke L, Jones WW, Mitra A, Riviere J. Applying the biopharmaceutics classification system to veterinary pharmaceutical products. Part II. Physiological considerations. Adv Drug Deliv Rev. 2002;54:825\u201350.","journal-title":"Adv Drug Deliv Rev"},{"key":"55_CR6","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/j.addr.2004.02.013","volume":"56","author":"SC Sutton","year":"2004","unstructured":"Sutton SC. Companion animal physiology and dosage form performance. Adv Drug Deliv Rev. 2004;56:1383\u201398.","journal-title":"Adv Drug Deliv Rev"},{"key":"55_CR7","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.ejpb.2013.01.010","volume":"84","author":"M Arndt","year":"2013","unstructured":"Arndt M, Chokshi H, Tang K, Parrott NJ, Reppas C, Dressman JB. Dissolution media simulating the proximal canine gastrointestinal tract in the fasted state. Eur J Pharm Biopharm. 2013;84:633\u201341.","journal-title":"Eur J Pharm Biopharm"},{"key":"55_CR8","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1208\/s12249-014-0075-1","volume":"15","author":"H Zhang","year":"2014","unstructured":"Zhang H, Xia B, Sheng J, Heimbach T, Lin TH, He H, et al. Application of physiologically based absorption modeling to formulation development of a low solubility, low permeability weak base: mechanistic investigation of food effect. AAPS PharmSciTech. 2014;15:400\u20136.","journal-title":"AAPS PharmSciTech"},{"key":"55_CR9","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1208\/s12248-009-9099-y","volume":"11","author":"M Jamei","year":"2009","unstructured":"Jamei M, Turner D, Yang J, Neuhoff S, Polak S, Rostami-Hodjegan A, et al. Population-based mechanistic prediction of oral drug absorption. AAPS J. 2009;11:225\u201337.","journal-title":"AAPS J"},{"key":"55_CR10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ejps.2014.02.010","volume":"57","author":"E Sj\u00f6gren","year":"2014","unstructured":"Sj\u00f6gren E, Abrahamsson B, Augustijns P, Becker D, Bolger MB, Brewster M, et al. In vivo methods for drug absorption\u2014comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for formulation\/API\/excipient characterization including food effects. Eur J Pharm Sci. 2014;57:99\u2013151.","journal-title":"Eur J Pharm Sci"},{"key":"55_CR11","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1208\/s12248-016-9913-2","volume":"18","author":"M Martinez","year":"2016","unstructured":"Martinez M, Mistry B, Lukacova V, Polli J, Hoag S, Dowling T, et al. Use of modeling and simulation tools for understanding the impact of formulation on the absorption of a low solubility compound: ciprofloxacin. AAPS J. 2016;18:886\u201397.","journal-title":"AAPS J"},{"key":"55_CR12","unstructured":"USP29 monographs, ciprofloxacin www.pharmacopeia.cn\/v29240\/usp29nf24s0_m17865.html ."},{"key":"55_CR13","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/bdd.1809","volume":"33","author":"H Arakawa","year":"2012","unstructured":"Arakawa H, Shirasaka Y, Haga M, Nakanishi T, Tamai I. Active intestinal absorption of fluoroquinolone antibacterial agent ciprofloxacin by organic anion transporting polypeptide, Oatp1a5. Biopharm Drug Dispos. 2012;33:332\u201341.","journal-title":"Biopharm Drug Dispos"},{"key":"55_CR14","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1124\/dmd.111.038323","volume":"39","author":"IS Haslam","year":"2011","unstructured":"Haslam IS, Wright JA, O\u2019Reilly DA, Sherlock DJ, Coleman T, Simmons NL. Intestinal ciprofloxacin efflux: the role of breast cancer resistance protein (ABCG2). Drug Metab Dispos. 2011;39:2321\u20138.","journal-title":"Drug Metab Dispos"},{"issue":"Suppl 1","key":"55_CR15","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/S0169-409X(01)00179-X","volume":"50","author":"B Agoram","year":"2001","unstructured":"Agoram B, Woltosz WS, Bolger MB. Predicting the impact of physiological and biochemical processes on oral drug bioavailability. Adv Drug Deliv Rev. 2001;50 Suppl 1:S41\u201367.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"55_CR16","doi-asserted-by":"publisher","first-page":"E4","DOI":"10.1208\/ps050104","volume":"5","author":"BA Hendriksen","year":"2003","unstructured":"Hendriksen BA, Felix MV, Bolger MB. The composite solubility versus pH profile and its role in intestinal absorption prediction. AAPS PharmSci. 2003;5(1):E4.","journal-title":"AAPS PharmSci"},{"key":"55_CR17","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1023\/A:1018917729477","volume":"10","author":"ATK Lu","year":"1993","unstructured":"Lu ATK, Frisella ME, Johnson KC. Dissolution modeling: factors affecting the dissolution rates of polydisperse powders. Pharm Res. 1993;10:1308\u201314.","journal-title":"Pharm Res"},{"key":"55_CR18","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1023\/A:1016062224568","volume":"13","author":"SD Mithani","year":"1996","unstructured":"Mithani SD, Bakatselou V, TenHoor CN, Dressman JB. Estimation of the increase in solubility of drugs as a function of bile salt concentration. Pharm Res. 1996;13:163\u20137.","journal-title":"Pharm Res"},{"key":"55_CR19","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/bdd.2510160502","volume":"16","author":"TT Kararli","year":"1995","unstructured":"Kararli TT. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharm Drug Dispos. 1995;16:351\u201380.","journal-title":"Biopharm Drug Dispos"},{"key":"55_CR20","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1002\/jps.23159","volume":"101","author":"KM Mahar","year":"2012","unstructured":"Mahar KM, Portelli S, Coatney R, Chen EP. Gastric pH and gastric residence time in fasted and fed conscious beagle dogs using the Bravo pH system. J Pharm Sci. 2012;101:2439\u201348.","journal-title":"J Pharm Sci"},{"key":"55_CR21","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.2460\/ajvr.73.7.1085","volume":"73","author":"MG Papich","year":"2012","unstructured":"Papich MG. Ciprofloxacin pharmacokinetics and oral absorption of generic ciprofloxacin tablets in dogs. Am J Vet Res. 2012;73:1085\u201391.","journal-title":"Am J Vet Res"},{"key":"55_CR22","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/j.1365-2885.1994.tb00264.x","volume":"17","author":"AR Abad\u00eda","year":"1994","unstructured":"Abad\u00eda AR, Aramayona JJ, Mu\u00f1oz MJ, Pla Delfina JM, Saez MP, Bregante MA. Disposition of ciprofloxacin following intravenous administration in dogs. J Vet Pharmacol Ther. 1994;17:384\u20138.","journal-title":"J Vet Pharmacol Ther"},{"key":"55_CR23","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.1439-0442.1995.tb00405.x","volume":"42","author":"AR Abadia","year":"1995","unstructured":"Abadia AR, Aramayona JJ, Mu\u00f1oz MJ, Pla Delfina JM, Bregante MA. Ciprofloxacin pharmacokinetics in dogs following oral administration. Zentralbl Veterinarmed A. 1995;42:505\u201311.","journal-title":"Zentralbl Veterinarmed A"},{"key":"55_CR24","doi-asserted-by":"publisher","first-page":"434","DOI":"10.2165\/00003088-199019060-00003","volume":"19","author":"K Vance-Bryan","year":"1990","unstructured":"Vance-Bryan K, Guay DR, Rotschafer JC. Clinical pharmacokinetics of ciprofloxacin. Clin Pharmacokinet. 1990;19:434\u201361.","journal-title":"Clin Pharmacokinet"},{"key":"55_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1753-5174.2010.00032.x","volume":"4","author":"MS Park","year":"2011","unstructured":"Park MS, Okochi H, Benet LZ. Is ciprofloxacin a substrate of P-glycoprotein? Arch Drug Inf. 2011;4:1\u20139.","journal-title":"Arch Drug Inf"},{"key":"55_CR26","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1021\/mp500330y","volume":"11","author":"M Drozdzik","year":"2014","unstructured":"Drozdzik M, Gr\u00f6er C, Penski J, Lapczuk J, Ostrowski M, Lai Y, et al. Protein abundance of clinically relevant multidrug transporters along the entire length of the human intestine. Mol Pharm. 2014;11:3547\u201355.","journal-title":"Mol Pharm"},{"key":"55_CR27","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.bcp.2005.05.031","volume":"70","author":"H Gutmann","year":"2005","unstructured":"Gutmann H, Hruz P, Zimmermann C, Beglinger C, Drewe J. Distribution of breast cancer resistance protein (BCRP\/ABCG2) mRNA expression along the human GI tract. Biochem Pharmacol. 2005;70:695\u20139.","journal-title":"Biochem Pharmacol"},{"key":"55_CR28","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1124\/dmd.112.045443","volume":"40","author":"S Haller","year":"2012","unstructured":"Haller S, Schuler F, Lazic SE, Bachir-Cherif D, Kr\u00e4mer SD, Parrott NJ, et al. Expression profiles of metabolic enzymes and drug transporters in the liver and along the intestine of beagle dogs. Drug Metab Dispos. 2012;40:1603\u201310.","journal-title":"Drug Metab Dispos"},{"key":"55_CR29","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3892\/etm.2012.777","volume":"5","author":"SM Cho","year":"2013","unstructured":"Cho SM, Park SW, Kim NH, Park JA, Yi H, Cho HJ, et al. Expression of intestinal transporter genes in beagle dogs. Exp Ther Med. 2013;5:308\u201314.","journal-title":"Exp Ther Med"},{"key":"55_CR30","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1177\/0091270002250613","volume":"43","author":"H Zhou","year":"2003","unstructured":"Zhou H. Pharmacokinetic strategies in deciphering atypical drug absorption profiles. J Clin Pharmacol. 2003;43:211\u201327.","journal-title":"J Clin Pharmacol"},{"key":"55_CR31","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ejps.2005.08.011","volume":"27","author":"M Kuentz","year":"2006","unstructured":"Kuentz M, Nick S, Parrott N, R\u00f6thlisberger D. A strategy for preclinical formulation development using GastroPlus as pharmacokinetic simulation tool and a statistical screening design applied to a dog study. Eur J Pharm Sci. 2006;27:91\u20139.","journal-title":"Eur J Pharm Sci"},{"key":"55_CR32","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1007\/s11095-006-0207-8","volume":"23","author":"L Kalantzi","year":"2006","unstructured":"Kalantzi L, Persson E, Polentarutti B, Abrahamsson B, Goumas K, Dressman JB, et al. Canine intestinal contents vs. simulated media for the assessment of solubility of two weak bases in the human small intestinal contents. Pharm Res. 2006;23:1373\u201381.","journal-title":"Pharm Res"}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-017-0055-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12248-017-0055-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-017-0055-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T06:15:08Z","timestamp":1568873708000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12248-017-0055-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,6]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["55"],"URL":"https:\/\/doi.org\/10.1208\/s12248-017-0055-y","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,6]]}}}